| Literature DB >> 22558318 |
Lisa M Schechter1, Joy C Valenta, David J Schneider, Alan Collmer, Eric Sakk.
Abstract
Bacterial type III secretion systems (T3SSs) deliver proteins called effectors into eukaryotic cells. Although N-terminal amino acid sequences are required for translocation, the mechanism of substrate recognition by the T3SS is unknown. Almost all actively deployed T3SS substrates in the plant pathogen Pseudomonas syringae pathovar tomato strain DC3000 possess characteristic patterns, including (i) greater than 10% serine within the first 50 amino acids, (ii) an aliphatic residue or proline at position 3 or 4, and (iii) a lack of acidic amino acids within the first 12 residues. Here, the functional significance of the P. syringae T3SS substrate compositional patterns was tested. A mutant AvrPto effector protein lacking all three patterns was secreted into culture and translocated into plant cells, suggesting that the compositional characteristics are not absolutely required for T3SS targeting and that other recognition mechanisms exist. To further analyze the unique properties of T3SS targeting signals, we developed a computational algorithm called TEREE (Type III Effector Relative Entropy Evaluation) that distinguishes DC3000 T3SS substrates from other proteins with a high sensitivity and specificity. Although TEREE did not efficiently identify T3SS substrates in Salmonella enterica, it was effective in another P. syringae strain and Ralstonia solanacearum. Thus, the TEREE algorithm may be a useful tool for identifying new effector genes in plant pathogens. The nature of T3SS targeting signals was additionally investigated by analyzing the N-terminus of FtsX, a putative membrane protein that was classified as a T3SS substrate by TEREE. Although the first 50 amino acids of FtsX were unable to target a reporter protein to the T3SS, an AvrPto protein substituted with the first 12 amino acids of FtsX was translocated into plant cells. These results show that the T3SS targeting signals are highly mutable and that secretion may be directed by multiple features of substrates.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22558318 PMCID: PMC3338616 DOI: 10.1371/journal.pone.0036038
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Schematic diagram of AvrPto mutants examined in this study.
Plasmids were constructed that express wild-type or mutant versions of the avrPto gene fused in frame to either FLAG epitope tag sequences or cya (calmodulin-dependent adenylate cyclase). Each gene was expressed from an upstream lac promoter (P). The sequences of the first 50 amino acids of each protein are shown above the avrPto gene. Amino acids in the mutant proteins that differ from the wild-type AvrPto sequence are underlined. Dashes within the AvrPtoΔ2–12 sequence indicate deleted residues.
Figure 2Secretion of AvrPtoWT and AvrPtoSSM by DC3000.
Wild-type and T3SS mutant (Δhrp) DC3000 strains containing plasmids that express AvrPtoWT or AvrPtoSSM were grown in hrp-derepressing fructose minimal medium (HDM). Cultures were separated into cellular and supernatant fractions by centrifugation and filtration, and an immunoblot analysis was performed after electrophoresis of protein samples through a 12.5% SDS–PAGE gel. The supernatant samples are 15-fold more concentrated than the cellular samples. The 21 kDa AvrPtoWT and AvrPtoSSM proteins were detected using primary antibodies against the FLAG epitope. The NptII protein (29.1 kDa) expressed from pUFR034 was also detected as a cytoplasmic control using primary antibodies against NptII. The results shown were taken from samples collected during a single experiment. Similar results were observed in an independently conducted experiment.
Figure 3Expression of AvrPto-Cya hybrid proteins in P. s. tomato DC3000.
DC3000 strains containing plasmids that express Cya fusion proteins were grown in culture and protein samples were separated in a 12.5% SDS–PAGE gel. An immunoblot analysis was performed using primary antibodies against Cya. The protein in each lane and its estimated molecular weight is: Lane 1, empty vector; lane 2, AvrPtoΔ2–12-Cya (60.9 kDa); lane 3, AvrPtoWT(1–164)-Cya (62.0 kDa); lane 4, AvrPtoWT(1–50)-Cya (48.9 kDa); lane 5, AvrPtoSSM(1–164)-Cya (61.9 kDa); lane 6, AvrPtoSSM(1–50)-Cya (48.9 kDa); lane 7, AvrPtoFtsX(1–12)-Cya (62.1 kDa); lane 8, AvrPtoTccB(1–12)-Cya (62.2 kDa); lane 9, FtsX1–50-Cya (50.8 kDa). The positions of protein standards on the gel are indicated to the left of the blot.
Translocation of AvrPto-Cya hybrid proteins into N. benthamiana by P. s. tomato DC3000.
| Cya fusion protein | Translocation by DC3000 (pmol cAMP/µg protein) | |
| Wild-type | Δ | |
| AvrPtoWT(1–164) | 139.3±5.5 | 0.2±0.2 |
| AvrPtoWT(1–50) | 112.6±14.2 | 0.6±0.2 |
| AvrPtoSSM(1–164) | 152.3±15.1 | 0.8±0.6 |
| AvrPtoSSM(1–50) | 124.4±19.3 | 0.8±0.2 |
DC3000 T3SS substrates and their scores after analysis by the TEREE algorithm.
| Substrate | Score | Amino acid sequence used to construct the T3SS substrate training set |
| HrpA1 | −19 |
|
| HrpH1 | −14 |
|
| HrpJ1 | −27 |
|
| HrpK1 | −15 |
|
| HrpW1 | −29 |
|
| HrpZ1 | −27 |
|
| HopAK1 | −31 |
|
| AvrE1 | −25 |
|
| AvrPto1 | −35 |
|
| HopA1 | −15 |
|
| HopB1 | −33 |
|
| HopC1 | −40 |
|
| HopD* | −31 | |
| HopD1 | −35 |
|
| HopE1 | −27 |
|
| HopF2 | −39 |
|
| HopG1 | −21 |
|
| HopH1 | −19 |
|
| HopI1 | −24 |
|
| HopK1 | −35 |
|
| HopM1 | −37 |
|
| HopN1 | −23 |
|
| HopO1-1 | −47 |
|
| HopO1-2 | −36 |
|
| HopO1-3* | −29 | |
| HopP1* | −22 | |
| HopQ1-1 | −34 |
|
| HopR1 | −23 |
|
| HopS1* | −19 | |
| HopS2 | −17 |
|
| HopT1-1 | −31 |
|
| HopT1-2* | −26 | |
| HopU1 | −23 |
|
| HopV1 | −22 |
|
| HopX1 | −34 |
|
| HopY1 | −25 |
|
| HopAA1-1 | −33 |
|
| HopAA1-2 | −29 | |
| HopAB2 | −43 |
|
| HopAD1 | −26 |
|
| HopAF1 | −43 |
|
| HopAG* | −15 | |
| HopAH1 | −39 |
|
| HopAH2-1* | −19 | |
| HopAH2-2* | +2 | |
| HopAI1 | −11 |
|
| HopAM1-1 | −38 |
|
| HopAM1-2* | −38 | |
| HopAO1* | −29 | |
| HopAQ1* | −33 | |
| HopAS1* | −25 | |
| PSPTO_0907* | −21 |
Experimentally validated T3SS substrates that were not included in the positive training set are denoted by asterisks.
Figure 4Entropy estimates for the N-terminal regions of DC3000 T3SS substrates and nonsecreted proteins.
The dashed line represents the negative (background) training set, whereas the dotted line represents the T3SS substrate set. The estimates were calculated for residues 2–47 using a sliding window size of 3.
Comparison of TEREE to other computational T3SS substrate prediction models.
| Genome | Method | Sensitivity | Specificity | # of known T3SS substrates in top 50 hits |
|
| TEREE | 78.1% | 98.7% | 20 |
| SIEVE | 87.5% | 90.1% | 9 | |
|
| TEREE | 20.5% | 98.8% | 8 |
| SIEVE | 86.4% | 91.9% | 9 | |
|
| TEREE | 50.0% | 98.2% | 28 |
| BPBAc | 63.9% | 99.0% | 42 |
Values were calculated by dividing the number of validated effectors, or true positives, by the sum of the true positives and false negatives. The second columns of Tables S3, S4, and S5 list the validated effectors for P. s. phaseolicola 1448a, S. e. Typhimurium LT2, and R. solanacearum GMI1000, respectively.
Values were calculated by dividing the number of true negatives (non-substrates of the T3SS) by the sum of the false positives and true negatives.
The sensitivity and specificity values for SIEVE and BPBAc were calculated based on published data sets [38], [43].
Translocation of unlikely T3SS substrates into N. benthamiana by P. s. tomato DC3000.
| Cya fusion protein | Translocation by DC3000 (pmol cAMP/µg protein) | |
| Wild-type | Δ | |
| FtsX(1–50) | 4.0±0.5 | 0.3±0.1 |
| AvrPtoWT(1–164) | 155.4±23.5 | 0.5±0.1 |
| AvrPtoΔ2–12 | 7.5±1.0 | 0.1±0.0 |
| AvrPtoFtsX(1–12) | 107.0±8.2 | 0.0±0.0 |
| AvrPtoTccB(1–12) | 118.5±8.5 | 0.0±0.0 |
Computational T3SS substrate predictions for proteins experimentally tested in this study.
| Protein | Computational T3SS substrate predictions | Experimental results | ||||
| TEREE | SIEVE | Effective T3 | T3SS prediction | T3SEdb | ||
| AvrPtoWT | + | + | + | +/+ | + | + |
| AvrPtoSSM | + | + | +/− | +/+ | + | + |
| FtsX (PSPTO_0429) | + | − | +/− | +/− | + | − |
| TccB (PSPTO_4342) | − | − | − | −/− | − | − |
| AvrPtoΔ2–12 | + | − | + | +/+ | + | − |
| AvrPtoFtsX(1–12) | + | − | + | +/+ | + | + |
| AvrPtoTccB(1–12) | + | − | + | +/+ | + | + |
This model could be run at more stringent (selective) or less stringent (sensitive) settings. Symbols in this column indicate that the protein was classified as a T3SS substrate at: (+) the selective level, (+/−) the sensitive level, or (−) neither level.
This model could be run using either an ANN or SVM classifer. Symbols in this column indicate that the protein was classified as a T3SS substrate using: (+/−) ANN, (−/+) SVM, (+/+) both, or (−/−) neither classifiers.
Bacterial strains and plasmids used in this study.
| Strain or Plasmid | Genotype or relevant characteristics | Source |
|
| ||
| DH5α | F− Φ80 | Invitrogen |
| TOP10 | F−
| Invitrogen |
|
| ||
| DC3000 | Wild type; Rfr |
|
| CUCPB5114 | DC3000 Δ |
|
| Plasmids | ||
| pUFR034 | Broad-host-range vector; Kmr |
|
| pFLAG-CTC | Vector for expression of C-terminal FLAG fusion proteins; Apr | Sigma-Aldrich |
| pCPP3156 | pFLAG-CTC:: | This work |
| pBBR1MCS-5 | Broad-host-range expression vector containing P | This work |
| pCPP3178 | pBBR1MCS-5:: | This work |
| pCPP3384 | pBBR1MCS-5:: | This work |
| pCPP3407 | pBBR1MCS-5:: | This work |
| pLMS153 | pBBR1MCS-5:: | This work |
| pLMS154 | pBBR1MCS-5:: | This work |
| pENTR/SD/D-TOPO | Gateway entry vector; Kmr | Invitrogen |
| pCPP5168 | pENTR/SD/D-TOPO:: | This work |
| pCPP3214 | Vector for expression of C-terminal Cya fusion proteins; Spr |
|
| pCPP3234 | Gateway destination vector version of pCPP3214; Spr, Cmr |
|
| pCPP5170 | pCPP3234:: | This work |
| pND1 | pCPP3214:: | This work |
| pND2 | pCPP3214:: | This work |
| pND3 | pCPP3214:: | This work |
| pND4 | pCPP3214:: | This work |
| pLMS155 | pCPP3214:: | This work |
| pLMS157 | pCPP3214:: | This work |
| pLMS158 | pCPP3214:: | This work |
Rfr, Cmr, Apr, Gmr, Spr, and Kmr indicate resistance to rifampicin, chloramphenicol, ampicillin, gentamicin, spectinomycin, and kanamycin, respectively.
Oligonucleotides used in this study.
| Name | Sequence |
| P403C |
|
| P830C |
|
| P831C |
|
| P832C |
|
| P154 |
|
| P155 |
|
| P156 |
|
| P157 |
|
| APS1 |
|
| APS2 |
|
| APS3 |
|
| APS4 |
|
| P1 |
|
| P2 |
|
| P3 |
|
| P1211C |
|
| P1256C |
|
Important restriction enzyme sites are underlined.